David, L.
(Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 2012)
This article is a review of the current evidence of the cardiovascular (CV) effects of antidiabetic agents. Metformin has been demonstrated to reduce
CV disease risk, especially in overweight diabetic patients. Some ...